| 1 |
2026.06.18 G.S.R. 496(E)_Notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Act |
2026-Jun-18 |
|
694 KB |
| 2 |
2026.06.11 S.O. 3068(E) to S.O. 3083(E)_ Prohibition of 16 FDC's |
2026-Jun-11 |
|
1447 KB |
| 3 |
2026.06.09 G.S.R. 477(E)_Notification for Removal of Syrup exemption under schedule K in the Drugs Rules,1945 |
2026-Jun-09 |
|
1072 KB |
| 4 |
2026.06.01 G.S.R. 444(E)_Notification for amendment in Schedule V w.r.t. unit of measurement of Folic Acid under the Drugs Rules, 1945 |
2026-Jun-01 |
|
552 KB |
| 5 |
2026.05.22 G.S.R. 407(E)_Notification for Revision of testing fees under Schedule B and B1 of Drugs and Cosmetics Actâ |
2026-May-22 |
|
1486 KB |
| 6 |
2026.05.13 G.S.R. 377(E)_Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations |
2026-May-13 |
|
541 KB |
| 7 |
2026.04.21 G.S.R. 299(E)_ Draft Notification for amendment under Rule 89 of Drugs Rules 1945, for obtaining licence under Form 29 for different categories falling under Form 25A, 25F, 28A, 28B, 28D, 28DA, 28E, 28F |
2026-Apr-21 |
|
1053 kb |
| 8 |
2026.04.10_ G.S.R. 270(E)_Draft Notification to amend certain provisions under Medical Devices Rules, 2017 EU |
2026-Apr-10 |
|
758 KB |
| 9 |
2026.04.10_G.S.R. 269(E)_Draft Notification to amend certain provisions w.r.t. Medical Device Testing Fee under MDR, 2017 |
2026-Apr-10 |
|
716 KB |
| 10 |
2026.03.09 G.S.R. 173(E)_Draft Notification reg PAC for amendment in Drugs Rules, 1945 |
2026-Mar-09 |
|
785 KB |
| 11 |
2026.03.09 G.S.R. 164(E)_Draft Notification regarding Blood product testing under Drugs Rules,1945 |
2026-Mar-09 |
|
619 KB |
| 12 |
2026.03.02 G.S.R. 165(E)_Inclusion of Qualifications of Inspector Medical Devices and Government Analyst |
2026-Mar-02 |
|
726 KB |
| 13 |
2026.02.18 S.O. 912(E)_Notification of Medical Device Testing Officers (MDTO) for Laboratories |
2026-Feb-18 |
|
1137 KB |
| 14 |
2026.02.16 G.S.R. 135(E)_Notification for amendment in certain Drugs Rules (Related to Rule 121 â Test for Pyrogen, Footnote of Schedule H, condition of license under Form 20B, 20BB, 21B, 21BB, inclusion of name of competent person in Form 20G) |
2026-Feb-16 |
|
1156 KB |
| 15 |
2026.02.02 G.S.R. 97(E)_Draft Notification regarding submission of post approval changes in NDCT, Rules 2019 |
2026-Feb-02 |
|
1176 KB |
| 16 |
2026.02.02 G.S.R. 98(E)_Draft Notification regarding amendment in NDCT Rules, 2019 for Omit the requirements of granting of Provisional Certificate for registration of ethics committee. |
2026-Feb-02 |
|
1060 KB |
| 17 |
2026.01.28 G.S.R. 65(E)_Draft notification of Chaudhary Charan Singh National Institute of Animal Health, Baghpat, UP, as a CDL for testing viral and bacterial veterinary vaccines under the D and C Ac |
2026-Jan-28 |
|
703 KB |
| 18 |
2026.01.28 G.S.R. 66(E)_Draft Notification for consideration of Navi Mumbai International Airport (NMIA) as authorized Airport for Drug Import, under the provision of Rule 43A of Drugs Rules 1945 |
2026-Jan-28 |
|
656 KB |
| 19 |
2026.01.22 G.S.R. 52(E)_Draft Notification for Revision of testing fees under Schedule B and B1 |
2026-Jan-22 |
|
983 KB |
| 20 |
2026.01.21 G.S.R. 50(E)_Notification for amendment in NDCT Rules, 2019 for online intimation mechanism for BA BE studies of unapproved drugs for export purpose |
2026-Jan-21 |
|
809 KB |
| 21 |
2026.01.21 G.S.R. 51(E)_ Draft Notification regarding Blue line on Label of Antimicrobial |
2026-Jan-21 |
|
620 KB |
| 22 |
2026.01.21 G.S.R. 54(E)_Draft Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations |
2026-Jan-21 |
|
618 KB |
| 23 |
2026.01.21 G.S.R. 53(E)_Draft Notification for amendment in Schedule V w.r.t. unit of measurement of Folic Acid under the Drugs Rules, 1945 |
2026-Jan-21 |
|
629 KB |
| 24 |
2026.01.20 G.S.R. 45(E)_ Draft Notification for exemption of Animal Toxicity Studies w.r.t. certain conditions |
2026-Jan-20 |
|
658 KB |
| 25 |
2026.01.20_G.S.R. 46(E)_Notification about changes to requirements of Test license under NDCT Rules 2019 â |
2026-Jan-20 |
|
733 KB |
| 26 |
2025.12.29_ S.O. 6091(E)_Notification regarding Nimesulide above 100 mg in immediate release dosage form |
2025-Dec-30 |
|
543 KB |
| 27 |
2025.12.29_G.S.R. 927(E)_Draft notification for Removal of Syrup exemption under schedule K |
2025-Dec-30 |
|
641 KB |
| 28 |
2025.12.04_ G.S.R. 883(E)_Draft Notification for amendment in Medical Device Rules, 2017 |
2025-Dec-15 |
|
1343 KB |
| 29 |
G.S.R 810( E) Dated 31.10.2025 Corrigendum to G.S.R 587( E) Dated 27.08.2025 regarding Draft Notification for application of unapproved drugs for conduct of BA BE studies for export purpose under NDCT Rules 2019 |
2025-Oct-31 |
|
544 KB |
| 30 |
2025.10.16_ G.S.R. 757(E)_ Amendment under Drugs Rules to include more categories under Schedule H2 |
2025-Oct-16 |
|
793 KB |
| 31 |
2025.10.16_ G.S.R. 758(E)_ Inclusion of additional items under CLAA in Drugs Rules 1945 |
2025-Oct-16 |
|
654 KB |
| 32 |
2025.10.16_ G.S.R. 756(E)_ Draft Notification regarding Debarment of applicant for submitting misleading, or fake, or Fabricated Documents, information |
2025-Oct-16 |
|
1993 KB |
| 33 |
2025.10.16_G.S.R. 759(E) _ Notification of liquid anticeptic for household use or hospital and ohter than household use under Drug Rules |
2025-Oct-16 |
|
727 KB |
| 34 |
2025.10.16_ G.S.R. 760(E)_Notification regarding restriction of sale of drug products containing alcohol content under Drugs Rules 1945 |
2025-Oct-16 |
|
633 KB |
| 35 |
2025.10.10_ G.S.R. 748(E)_Inclusion of Qualifications of Inspector Medical Devices and Government Analyst |
2025-Oct-10 |
|
622 KB |
| 36 |
2025.09.23_S.O. 4338(E)_prohibit the import, manufacture, sale and distribution of certain antimicrobial products for animal use |
2025-Sep-23 |
|
1911 KB |
| 37 |
2025.08.27_G.S.R. 587(E)_Draft Notification for application of unapproved drugs for conduct of BA BE studies for export purpose under NDCT Rules 2019 |
2025-Aug-27 |
|
728 KB |
| 38 |
2025.08.27_G.S.R. 588(E)_Draft Notification about changes to requirements of Test license under NDCT Rules 2019 |
2025-Aug-27 |
|
635 KB |
| 39 |
2025.08.18_G.S.R. 554(E)_Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945 |
2025-Aug-18 |
|
746 KB |
| 40 |
2025.08.01_S.O. 3551(E)_Appointment of Compounding Authority under the Drugs and Cosmetics (Compounding of Offences) Rules, 2025 |
2025-Aug-01 |
|
771 KB |
| 41 |
2025.07.29_G.S.R. 513(E)_Certain amendments in Cosmetics Rule 2020 |
2025-Jul-29 |
|
2070 KB |
| 42 |
2025.05.28_G.S.R. 345(E)_Draft notification for amendment in certain Drugs Rules (Related to Rule 121 â Test for Pyrogen, Footnote of Schedule H, condition of license under Form 20B, 20BB, 21B, 21BB, inclusion of name of competent person in Form 20G) |
2025-May-28 |
|
1416 KB |
| 43 |
2025.05.22_S.O. 2298(E)_Notification to prohibit the import, manufacture, sale and distribution of certain antimicrobial products for animal use |
2025-May-22 |
|
1150 KB |
| 44 |
2025.05.16_S.O. 2208 and S.O. 2209_Notification of Director Incharge, CDL Kolkata |
2025-May-16 |
|
1843 KB |
| 45 |
2025.04.24_G.S.R. 259(E)_Notification reg rules for Compounding of offences under Jan Vishwas Act |
2025-Apr-24 |
|
1292 KB |
| 46 |
S.O. 1717(E) dt 15.04.2025_Restriction of the Fixed Dose Combination of Chlorpheniramine Maleate and Phenylephrine Hydrochloride |
2025-Apr-15 |
|
819 KB |
| 47 |
2025.03.27_S.O. 203(E)_Notification of Government Analysts at National Institute of Biologicals, Noida |
2025-Mar-27 |
|
1856 KB |
| 48 |
2025.03.12_S.O. 1159(E)_Reconstitution of Drugs Technical Advisory Board (DTAB) |
2025-Mar-12 |
|
1892 KB |
| 49 |
2025.03.12_S.O. 1158(E)_Banning of Chloramphenicol and Nitrofurans in food rearing animal systems |
2025-Mar-12 |
|
1782 KB |
| 50 |
2025.02.11 G.S.R. 127(E) Notification reg Extension of timeline for implementation of Schedule M |
2025-Feb-11 |
|
1844 KB |
| 51 |
2025.01.30_ S.O. 558(E)_Notification of IVRI Veterinary Government Analyst |
2025-Jan-30 |
|
1685 KB |
| 52 |
2025.01.04_G.S.R. 10(E)_ Notification for Extension of Schedule M |
2025-Jan-04 |
|
1815 KB |
| 53 |
2025.01.06_G.S.R. 11(E)_Corrigendum to G.S.R 10(E) dated 04.01.2025 reg Extension of Schedule M |
2025-Jan-04 |
|
1631 KB |
| 54 |
2024.12.30_S.O. 5633(E)_Notification regarding Banning Nimesulide for animal use |
2024-Dec-30 |
|
1,923 KB |
| 55 |
2024.12.10_MDR_S.O. 5330(E) reg Notification of MDTL (Surgical Gloves and Medical Examination Gloves). |
2024-Dec-10 |
|
63 KB |
| 56 |
2024.12.10_MDR_S.O. 5331(E)_reg Notification of Medical Device Testing Officers (MDTO) for Laboratories |
2024-Dec-10 |
|
61 KB |
| 57 |
2024.10.25_G.S.R. 666 (E)_Corrigendum to G.S.R 922(E) dated 28th December, 2023 |
2024-Oct-25 |
|
483 KB |
| 58 |
2024.09.25 S.O. 4197(E) Amendment for Government Analysts at CDL Kolkata |
2024-Sep-25 |
|
1730 KB |
| 59 |
2024.09.19_NDCTR_G.S.R. 581E Notification for registration of Clinical Research Organisation CRO |
2024-Sep-19 |
|
1910 KB |
| 60 |
2024.08.12_S.O. 3284(E)_Notification reg Prohibiton of Etodolac |
2024-Aug-12 |
|
1690 KB |
| 61 |
2024.08.12__DR_S.O. 3266(E) to 3267(E)_ Restriction of FDC (Naproxen + Esomeprazole and Naproxen + Pantoprazole) |
2024-Aug-12 |
|
1816 KB |
| 62 |
2024.08.12__DR_S.O. 3285(E) to 3440(E)_ Prohibition of 156 FDCs |
2024-Aug-12 |
|
3234 KB |
| 63 |
2024.07.12_DR_G.S.R. 391(E)_Inclusion of details of excipient on every strip of medicines under Rule 96, in sub-rule (7) of Drugs Rules, 1945 |
2024-Jul-12 |
|
1677 KB |
| 64 |
2024.07.10_DR_G.S.R. 375(E)_Notification for No Advertisements of Drugs Specified in Schedule G under Drugs Rules, 1945 |
2024-Jul-10 |
|
1703 KB |
| 65 |
2024.07.10_DR_G.S.R.374(E)_Notification reg rules for Compounding of offences under D & C Act |
2024-Jul-10 |
|
1746 KB |
| 66 |
2024.05.28 DR G.S.R. 293 E Inclusion of Cochin and Thiruvananthapuram Ports in Rule 43A of Drugs Rules, 1945 |
2024-May-28 |
|
717 KB |
| 67 |
2024.03.28_S.O. 1577(E)_implementation of Jan Vishwas (Amendment of Provisions) Act, 2023 related to Provisions of D & C Act |
2024-Mar-28 |
|
799 KB |
| 68 |
2024.03.18_DR_G.S.R. 216(E)_Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105 |
2024-Mar-18 |
|
1249 KB |
| 69 |
2024.02.27_DR_G.S.R. 139(E)_Notification of Bengaluru, Visakhapatnam, Cochin and Thiruvananthapuram Air Ports |
2024-Feb-27 |
|
1099 KB |
| 70 |
2024.02.06_S.O. 567(E)_Notification of Government Analysts for CDTL Indore |
2024-Feb-06 |
|
1141 KB |
| 71 |
2024.02.05 S.O. 476(E) Revoke of notification GSR 144(E) dated 17.02.2017 Oseltamivir and Zanamivir |
2024-Feb-05 |
|
908 KB |
| 72 |
2024.02.05_DR_G.S.R. 95(E)_Inclusion of Oseltamivir and Zanamivir in Schedule H1 |
2024-Feb-05 |
|
1158 KB |
| 73 |
2024.02.02_DR_G.S.R. 91(E)_ Notification of Government Analysts for NIB Noida |
2024-Feb-02 |
|
1046 KB |
| 74 |
2023.12.28_DR_Final G.S.R. 922(E)_Notification of Schedule M of Drugs Rules,1945. |
2023-Dec-28 |
|
3272 KB |
| 75 |
2023.11.07_S.O. 4834(E)_In compliance to the Jan Vishwas (Amendment of Provisions) Act, 2023 |
2023-Nov-07 |
|
657 KB |
| 76 |
2023.10.05 S.O. 4351(E) Notification of Government Analyst CDTL MUMBAI |
2023-Oct-05 |
|
883 KB |
| 77 |
DR_Draft_G.S.R. 687(E) dt_25.09.2023_Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105 |
2023-Sep-25 |
|
1310 KB |
| 78 |
DR_ Draft_G.S.R. 686 (E) dt_25.09.2023_Inclusion of Oseltamivir and Zanamivir in Schedule H1 |
2023-Sep-25 |
|
658 KB |
| 79 |
2023.07.31_DR_S.O. 3448(E)_Prohibition of Veterinary Drugs Ketoprofen and its formulation and Aceclofenac its Formulation |
2023-Jul-31 |
|
1085 KB |
| 80 |
02.06. 2023 G.S.R 409(E) Medical Devices |
2023-Jun-02 |
|
1157 KB |
| 81 |
2023.06.02_DR_S.O. 2394(E) to 2407(E)_Banning of 14 FDCs |
2023-Jun-02 |
|
1209 KB |
| 82 |
2023.06.02_DR_ G.S.R 410(E)_Notification of Gangavaram Port |
2023-Jun-02 |
|
1130 KB |
| 83 |
2023.05.15_S.O. 2191(E)_NIB Government Analyst Notification |
2023-May-15 |
|
603 KB |
| 84 |
2023.05.15_CR_Draft G.S.R. 371(E)_Certain amendments in Cosmetics Rule 2020 |
2023-May-15 |
|
1173 KB |
| 85 |
2023.05.11_DR_S.O. 2177(E) _Government Analyst Notification at CDL, Kolkata |
2023-May-11 |
|
618 KB |
| 86 |
2023.05.11_Draft_NDCTR_G.S.R. 364(E)_Notification for registration of Clinical Research Organisation (CRO) |
2023-May-11 |
|
1203 KB |
| 87 |
S.O. 1928(E)_25.04.2023_Notification for testing Covid kit NIB Noida |
2023-Apr-25 |
|
567 KB |
| 88 |
2023.03.09_NDCTR_G.S.R. 175(E)_ Amendment in First Schedule regarding use of induced Pluripotent Stem Cells additional testing methods |
2023-Mar-09 |
|
605 KB |
| 89 |
2023.03.01_MDR_Draft_ GSR 157(E)_Medical Device Rule 18 and 19 Amendment (Central Government and State Government) |
2023-Mar-01 |
|
642 KB |
| 90 |
2023.03.01_DR_Draft_GSR 158(E)_Notification of Gangavaram port |
2023-Mar-01 |
|
569 KB |
| 91 |
2023.02.08_S.O. 627(E)_Government Analyst Notification at CDTL Hyderabad |
2023-Feb-08 |
|
1317 KB |
| 92 |
NDCTR_G.S.R. 835(E) dt_22.11.2022_Amendment in First Schedule for non clinical testing methods for new drugs (Pluripotent) |
2022-Nov-22 |
|
1245 KB |
| 93 |
2022.11.17_Final GSR 823(E)_Amendment in rule 96 for mandating Bar or QR code on the label of top 300 brand in Drugs Rules |
2022-Nov-17 |
|
1363 KB |
| 94 |
2022.11.02_S.O. 5090(E)_Notification of eligible officers at CDTL Chennai as Govt Analyst under section 20 of the Drugs and Cosmetics Act 1940 |
2022-Nov-02 |
|
1357 KB |
| 95 |
2022.10.14_Final GSR 778(E)_Insertion of Provisions for deemed approvals in various rules under NDCTR 2019 |
2022-Oct-14 |
|
1209 KB |
| 96 |
MDR_G.S.R. 777(E) dt_14.10.2022_exemption of non sterile and non measuring Class A medical devices from licensing regime |
2022-Oct-14 |
|
1102 KB |
| 97 |
G.S.R 778 (E) dated 14 Oct 2022 regarding the New Drugs and Clinical Trials (Third Amendment) Rules 2022 |
2022-Oct-14 |
|
1209 KB |
| 98 |
G.S.R. 777(E) 14 Oct 2022 Final notification for exemption of non sterile and non measuring Class A medical devices from licensing regime |
2022-Oct-14 |
|
1020 KB |
| 99 |
GSR 754 (E) 30-09-2022 sale of medical device retail and wholesale |
2022-Sep-30 |
|
1348 KB |
| 100 |
2022.09.28_S.O._4573(E)_Notification for designation of RDTL Chandigarh also as CMDTL as per MDR 2017 |
2022-Sep-28 |
|
1291 KB |
| 101 |
2022.09.28_S.O. 4574(E)_Designation of Government Analysts at RDTL Chandigarh as MDTO as per MDR 2017 |
2022-Sep-28 |
|
1220 KB |
| 102 |
2022.09.20_Draft_GSR 710(E)_Exemption of certain Class A medical device from licensing regime |
2022-Sep-20 |
|
1300 KB |
| 103 |
2022.08.24_Final GSR 654(E)_Parallel submission in Form 28-D |
2022-Aug-24 |
|
1242 KB |
| 104 |
2022.08.10_S.O. 3758(E)_To authorize director incharge of CDL Kolkata for signing report of test of MD samples sent by Court of MD samples sent by Court of Laws. |
2022-Aug-10 |
|
766 KB |
| 105 |
2022.08.10_S.O. 3757(E)_Notification of Director Incharge of CDL Kolkata |
2022-Aug-10 |
|
1454 KB |
| 106 |
2022.08.10_Final GSR 623(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945. |
2022-Aug-10 |
|
1033 KB |
| 107 |
Extract of the New Drugs and Clinical Trials Rules 2019 relevant to Ethics Committee for Clinical Trial, Bioavailability and Bioequivalence study |
2022-Aug-08 |
|
354 KB |
| 108 |
2022.08.02_S.O. 3739(E)_Notification of Medical Devices Testing Officer for CMDTL |
2022-Aug-02 |
|
1126 KB |
| 109 |
2022.06.30_Final GSR 502(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules |
2022-Jun-30 |
|
1289 KB |
| 110 |
2022.06.15_Final GSR 450(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR |
2022-Jun-15 |
|
1348 KB |
| 111 |
22.06.14_Draft_GSR 448(E)_Amendment in rule 96 for mandating Bar code or QR code on the label of top 300 brand in Drugs Rules |
2022-Jun-14 |
|
1484 KB |
| 112 |
2022.05.25_Draft_GSR 393(E)_Exemption under Schedule K of the Drugs Rules, 1945 for OTC drugs |
2022-May-25 |
|
1504 KB |
| 113 |
2022.05.23_Draft GSR 382(E)_Parallel submission in Form 28-D |
2022-May-23 |
|
1149 KB |
| 114 |
2022.05.23_Draft GSR 383(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules |
2022-May-23 |
|
1145 KB |
| 115 |
2022.05.18_Final GSR 357(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945 |
2022-May-18 |
|
1314 KB |
| 116 |
2022.05.18_Final GSR 356(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017 |
2022-May-18 |
|
137 KB |
| 117 |
2022.03.29_Draft GSR 227(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945 |
2022-Mar-29 |
|
1572 KB |
| 118 |
2022.03.29_Draft GSR 228(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR |
2022-Mar-29 |
|
1427 KB |
| 119 |
2022.03.04_Final GSR 174(E)_Amendment of rule 36(3) MDR to include United Kingdom under MDR,2017 |
2022-Mar-04 |
|
1250 KB |
| 120 |
2022.02.24_Final GSR 158_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945 |
2022-Feb-24 |
|
1423 KB |
| 121 |
2022.02.24_Final GSR 158(E)_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945 |
2022-Feb-24 |
|
1423 KB |
| 122 |
2022.02.09_Draft GSR 104(E)_Regulation of sale of medical devices via registration of premises under MDR, 2017 |
2022-Feb-09 |
|
1520 KB |
| 123 |
2022.02.09_S.O. 553(E)_ Stockpiling of new drug under phase 3 of clinical trial_NDCTR,2019 |
2022-Feb-09 |
|
1106 KB |
| 124 |
2022.02.01_ Draft GSR 75(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945 |
2022-Feb-01 |
|
1364 KB |
| 125 |
2022.01.21_Draft_GSR 32(E)_Insertion of Provisions for deemed approvals in various rules under NDCTR 2019 |
2022-Jan-21 |
|
1483 KB |
| 126 |
2022.01.20_Final GSR 30(E)_Amendment of Sch K for Liquid Antiseptics at Sr. no 39 in Drugs Rules |
2022-Jan-20 |
|
1375 KB |
| 127 |
2022.01.18_Final GSR 19(E)_Amendment in rules 19B, 19C,19D &19E of MDR 2017 |
2022-Jan-18 |
|
1557 KB |
| 128 |
2022.01.18_Final GSR 20(E)_QR code for active pharmaceutical ingredients |
2022-Jan-18 |
|
1549 KB |
| 129 |
2022.01.18_Final GSR 21(E)_Amendment in Eighth Schedule, Form CT-03 |
2022-Jan-18 |
|
1361 KB |
| 130 |
2022.01.18_Draft GSR 23(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017 |
2022-Jan-18 |
|
1363 KB |
| 131 |
2022.01.13_Final GSR 14(E)_To amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019 |
2022-Jan-13 |
|
1169 KB |
| 132 |
2021.12.31_Final GSR 918(E)_Amendment of rnule 46 of MDR for Unique Device Identification |
2021-Dec-31 |
|
1335 KB |
| 133 |
2021.12.23_Draft S.O. 877(E)_Amendment of rule 46 of MDR for Unique Device Identificatio |
2021-Dec-23 |
|
1472 KB |
| 134 |
2021.12.10_S.O. 5139(E)_Renotification of NIB Noida as CDL for testing and lot release of COVID 19 vaccine |
2021-Dec-10 |
|
1337 KB |
| 135 |
2021.12.10_Draft GSR 850(E)_Amendment of rule 36(3) MDR to include United Kingdom |
2021-Dec-10 |
|
1222 KB |
| 136 |
2021.12.09_Final_GSR 848(E)_Notification of ICD Tihi,M.P. in rule 43A of Drugs Rules |
2021-Dec-09 |
|
1080 KB |
| 137 |
2021.11.29_GSR 839(E)_ Amendment of rule 24 and 24A of the Drugs Rules, 1945 to omit provisions for issuing duplicate copy of the Import licence and Registration certificate |
2021-Nov-29 |
|
1623 KB |
| 138 |
2021.11.29_ Draft GSR 840(E)_Amendment of rule 127 of the Drugs Rules 1945 for adding allura red in coal tar colour (List of colours permitted to be used in drugs) |
2021-Nov-29 |
|
1608 KB |
| 139 |
2021.10.27_Draft GSR 767(E) to amend rule 2 to substitute cell or stem cell derived product under NDCTR 2019 |
2021-Oct-27 |
|
4213 KB |
| 140 |
2021.10.27_Final GSR 766(E) reg Rule 90,Form 29 deemed approval |
2021-Oct-27 |
|
1173 KB |
| 141 |
2021.10.27_Final GSR 762(E) reg Oxytocin API import exclusivelyfor mfg for export purpose only |
2021-Oct-27 |
|
1274 KB |
| 142 |
2021.10.18_S.O. 4326(E)_Reconstitution of DTAB 2021 |
2021-Oct-18 |
|
1220 KB |
| 143 |
2021.10.12_Draft GSR 729(E)_Amendment in rules 19B, 19C,19D &19E of MDR 2017 |
2021-Oct-12 |
|
1230 KB |
| 144 |
2021.09.13_Draft GSR 628(E)_Amendment of Sch K for Liquid Antiseptics at Sr. no 39 |
2021-Sep-13 |
|
1523 KB |
| 145 |
2021.09.07_Draft GSR 618(E)_Amendment of rule 24 and 24A of Drugs Rules for duplicate copy of licence |
2021-Sep-07 |
|
150 KB |
| 146 |
2021.09.02_S.O. 3596(E)_Notification of Amar Jyoti, Dilip Sarkar, Rinku Kalita & Arun Kr Das as MDTO |
2021-Sep-02 |
|
1585 KB |
| 147 |
2021.09.01_Draft GSR 611(E)_Notification of ICD Tihi Indore under Rule 43A |
2021-Sep-01 |
|
1198 KB |
| 148 |
2021.08.31 Final G.S.R. 605(E) Standalone Bioanalytical laboratory Rule2 NDCTR 2019 |
2021-Aug-31 |
|
1634 KB |
| 149 |
2021.08.17_S.O. 3364(E)_Notification of National Institute of Animal Biotechnology (NIAB), Hyderabad for COVID vaccines |
2021-Aug-17 |
|
1245 KB |
| 150 |
2021.08.03_Draft G.S.R. 533(E)_Rule 90, Form 29 Deemed approval |
2021-Aug-03 |
|
1154 KB |
| 151 |
2021.08.02_Draft GSR 524(E)_Amendment in Eighth Schedule, Form CT-03 |
2021-Aug-02 |
|
1608 KB |
| 152 |
2021.07.22_Draft_GSR 502(E)_Rule 127 to insert IS4707(Part 1) by BIS |
2021-Jul-22 |
|
1160 KB |
| 153 |
2021.06.28_SO 2609(E)_Notification of NCCS Pune for COVID Vaccine testing valid till one year |
2021-Jun-28 |
|
1460 KB |
| 154 |
2021.06.25_SO 2572(E)_Notification of 172 Drugs Inspectors as MDO |
2021-Jun-25 |
|
1485 KB |
| 155 |
2021.06.22_SO 2450(E) Notification of Dilip Kr Panda Suparna Maitra as GA for CDL Kolkata |
2021-Jun-22 |
|
1127 KB |
| 156 |
2021.06.22_SO 2451(E)Notification of Sumir Rai Bhalla as GA for CDL Kasauli |
2021-Jun-22 |
|
1160 KB |
| 157 |
2021.06.22_SO 2449(E)_Notification of 14 Govt Analysts for CDTL Mumbai |
2021-Jun-22 |
|
1366 KB |
| 158 |
2021.04.08_S.O. 1521(E)_Amendment of S.O. 2808(E) dt 30.11.2012 for including three more GA at CDTL Mumbai |
2021-Apr-08 |
|
16252 KB |
| 159 |
2021.04.07_GSR 255(E)_For substitution at entry no 14. of GSR 578(E) dt 23.07.1983 reg FDC of tamsulosin+Deflazacort |
2021-Apr-07 |
|
1501 KB |
| 160 |
2021.04.07_GSR 258(E)_ Inclusion of Tapentadol in Sch H1 at S.No. 48 |
2021-Apr-07 |
|
1225 KB |
| 161 |
2021.04.07_S.O. 1520(E)_Notification of Raghuram Reddy Adidala, CDTL Hyderabad |
2021-Apr-07 |
|
1732 KB |
| 162 |
2021.03.19_S.O.1260(E)_Notification of Debasis Maitti and Hitesh Khare as Govt. Analysts at RDTL Chandigarh |
2021-Mar-19 |
|
1263 KB |
| 163 |
2021.03.12_S.O. 1170(E)_Notifying Amar jyoti, Dilip Kr, Rinku & Arun Kr at RDTL Guwahati as Govt. analyst |
2021-Mar-12 |
|
1452 KB |
| 164 |
2021.02.26_GSR 140(E)_Schedule K at serial number 23 to include Anganwadi worker |
2021-Feb-26 |
|
1369 KB |
| 165 |
2021.02.05_Draft GSR 98(E)_American Standard Test Method (ASTM) in the product standards for Medical Devices under Rule 7 of MDR-2017 |
2021-Feb-05 |
|
114 KB |
| 166 |
2021.02.05_Draft GSR 99(E)_For inclusion of provisions related to the registration of stand alone bio analytical laboratories in the NDCT Rules, 2019 |
2021-Feb-05 |
|
1092 KB |
| 167 |
2021.02.04_S.O. 529(E)_Notification of Dr. Sandeep Singh & Dr. Sweta Raghuvanshi for Scepticemia and Rankhet Vaccines |
2021-Feb-04 |
|
1578 KB |
| 168 |
Gazette notification G.S.R 763(E) dated 15.12.2020_Cosmetics Rules 2020 |
2020-Dec-15 |
|
2819 KB |
| 169 |
2020.11.26_S.O. 4244(E)_Extension of Import license amid COVID-19 Pandemic for 6 months |
2020-Nov-26 |
|
1384 KB |
| 170 |
2020.11.24_S.O. 4206(E)_Notifying of NIB Noida for testing COVID-19 Vaccine |
2020-Nov-24 |
|
1256 KB |
| 171 |
2020.10.21_Draft GSR 656(E)_Inclusion of Tapentadol in Sch H1.pdf |
2020-Oct-21 |
|
1153 KB |
| 172 |
S.O. 3722(E) dated 21.10.202 |
2020-Oct-21 |
|
1215 KB |
| 173 |
S.O. 2451(E)_Exemption of hand sanitizer from sale licence_Section 26B |
2020-Jul-27 |
|
1106 KB |
| 174 |
S.O. 2450(E) Dt. 27.07.2020_Reg. validity of existing Registration Certificate for import of drugs__Section 26B |
2020-Jul-27 |
|
1010 KB |
| 175 |
2020.06.05 Draft GSR 354 E compassionate use of new drug |
2020-Jun-05 |
|
1458 KB |
| 176 |
S.O.1511(E) Dt. 18.05.2020_Regulations for manufacture and stock of vaccines for COVID-19_Section 26B |
2020-May-18 |
|
1120 KB |
| 177 |
GSR 219(E) Dt. 26.03.2020_Sale of Hydroxychloroquine as per Schedule H1_Section 26B |
2020-Mar-26 |
|
1190 KB |
| 178 |
GSR 220(E) Dt. 26.03.2020_Doorstep delivery of the drugs by retail _Section 26B |
2020-Mar-26 |
|
1343 KB |
| 179 |
2020.18.03_ Final G.S.R. 166(E)_Amendment in Part X B & Part XII B pertains to Blood centre and Blood components |
2020-Mar-18 |
|
2041 KB |
| 180 |
2020-16-03_GSR 180 (E) banning of Chenodeoxycholic acid&Ursodeoxycholic acid extracted and prepareunder Section 10A |
2020-Mar-16 |
|
773 KB |
| 181 |
2020.02.13_Final G.S.R. 101(E)_Definition, Responsibility & labelling requirements for marketer of the drugs |
2020-Feb-13 |
|
787 KB |
| 182 |
G.S.R. 102(E)_dated 11.02.2020_ Registration of certain medical devices |
2020-Feb-11 |
|
1192 KB |
| 183 |
S.O. 648(E) dated 11.02.2020_ Medical Device Definition |
2020-Feb-11 |
|
902 KB |
| 184 |
2020.01.31_S.O. 481(E)_Sushil Kumar Sahu GA, CDL Kasauli |
2020-Jan-31 |
|
935 KB |
| 185 |
2020.01.27_G.S.R. 52(E) Exemption of Import of Oxytocin reference standards from Prohibition |
2020-Jan-27 |
|
668 KB |
| 186 |
2019.12.27 S.O.4671(E)_Extention of Effective date of S.O. 5980 (E) dated 03.12.2018 |
2019-Dec-27 |
|
242 KB |
| 187 |
Gazette Notification S.O. 4672 (E) dated 27 December 2019 |
2019-Dec-27 |
|
254 KB |
| 188 |
2019.11.26_S.O. 4271(E)_ Govt. Analyst at NIB Noida |
2019-Nov-26 |
|
368 KB |
| 189 |
Draft G.S.R. 827(E) Dated 06.11.2019_Amendment of entry no. 23 of Schedule K of D & C Rules, 1945 |
2019-Nov-06 |
|
319 KB |
| 190 |
2019.11.06_Final G.S.R. 828(E)_Condition of licence for undertaking on brand or trade names of drugs under D & C Rules, 1945 |
2019-Nov-06 |
|
332 KB |
| 191 |
2019.10.18_G.S.R. 797(E)_Registration of Certain Medical Devices_chapter-IIIA |
2019-Oct-18 |
|
370 KB |
| 192 |
2019.10.16_Final G.S.R 787(E) Exemption of State & Central Govt testing labs from NABL accreditation for two years under MDR 2017 |
2019-Oct-16 |
|
303 KB |
| 193 |
2019.10.16_S.O.3721 (E) Notification for Ultrasound equipment under 3b(iv) of D&C Act |
2019-Oct-16 |
|
270 KB |
| 194 |
2019.09.13_Final G.S.R.652(E)_Amendment in Form MD-10 to replace the SLA as issuing authority with CLA in MDR, 2017 |
2019-Sep-13 |
|
295 KB |
| 195 |
2019.09.13_Final G.S.R. 653(E)-Notification of ICD Dhannad Indore in MP for import of drugs under Rule 43A |
2019-Sep-13 |
|
242 KB |
| 196 |
2019.08.08_Draft_GSR 567(E)_QR code for active pharmaceutical ingredients |
2019-Aug-13 |
|
321 KB |
| 197 |
Advisory on labeling requirements for combi kit of Misoprostol and Mifepristone tablets for Medical Termination of Pregnancy (MTP) |
2019-Aug-09 |
|
516 KB |
| 198 |
Publication of a Gazette Notification of Drugs Inspector in CDSCO under Section 21 of D&C Act, 1940 (23 of 1940) |
2019-Aug-02 |
|
386 KB |
| 199 |
2019.07.19 S.O. 2607_Prohibition of Colistin for food producing animals, poultry, aqua farming and animal feed supplements under Sec.26A |
2019-Jul-19 |
|
293 KB |
| 200 |
2019.07.17_Final G.S.R. 499 (E)Consesquential amendments to GSR 1337(E) Dt. 27.10.2017 |
2019-Jul-17 |
|
361 KB |
| 201 |
2019.06.24 Draft G.S.R. 447(E) Definition Responsibility labelling requirements for marketer of the drugs |
2019-Jun-24 |
|
332 KB |
| 202 |
2019.04.18 Final G.S.R. 318(E) Amendment in Rule 91 and Second Schedule for fees of free sale certificate in the MDR 2017 |
2019-Apr-18 |
|
310 KB |
| 203 |
2019.04.02 S.O. 1500(E) Notification of Organ Preservative solution as drug under Section 3(b)(iv) |
2019-Apr-02 |
|
286 KB |
| 204 |
G.S.R.227(E) 19 March 2019 |
2019-Mar-21 |
|
2458 KB |
| 205 |
New Drugs and Clinical Trials Rules 2019 G.S.R. 227(E) |
2019-Mar-20 |
|
3456 KB |
| 206 |
2019.03.20 Final G.S.R. 231(E) Date of implementation of G.S.R.408(E) dated 26.04.2018 |
2019-Mar-20 |
|
305 KB |
| 207 |
The New Drugs Clinical Trials Rules, 2019 |
2019-Mar-19 |
|
2458 KB |
| 208 |
2019.03.18 Final G.S.R.223(E) Inclusion of Form 39A_Report of analysis by approved institution for individual or organization or procurement agency |
2019-Mar-18 |
|
345 KB |
| 209 |
2019.03.18 Final G.S.R.224(E) Amendment in Environmental requirements for mfg. of Medical Devices Annexure- A of the Fifth Schedule of MDR, 2017 |
2019-Mar-18 |
|
303 KB |
| 210 |
2019.03.11 Final G.S.R.213(E) Notifcation of Chaudhary Charan Singh National Institute of Animal Health, UP for testing of Veterinary Vaccines |
2019-Mar-11 |
|
317 KB |
| 211 |
2019.03.11 Draft G.S.R. 214(E) Notification of ICD Dhannad Indore in Madhya Pradesh for import of drugs under Rule 43A |
2019-Mar-11 |
|
315 KB |
| 212 |
2019.03.08 Final G.S.R. 205(E) Omission of provision for writing brand name in brackets in Rule 96 of D &C Rules, 1945 |
2019-Mar-08 |
|
301 KB |
| 213 |
2019.03.06_Draft G.S.R.187(E)_Amendment in Form 45 and Form 46 under Schedule-A of D&C Rules, 1945 |
2019-Mar-06 |
|
322 KB |
| 214 |
2019.03.06_Final G.S.R.186(E)_Hydroquinone included in Note to Schedule H of D & C Rules, 1945 |
2019-Mar-06 |
|
297 KB |
| 215 |
2019.03.06 Draft G.S.R.188(E) Amendment in Form MD-10 to replace the SLA as issuing authority with CLA in MDR, 2017 |
2019-Mar-06 |
|
314 KB |
| 216 |
2019.02.26_Final G.S.R. 153(E)_Date of implementation for G.S.R. 277(E) dated 23.03.2018 |
2019-Feb-26 |
|
315 KB |
| 217 |
2019.02.26_Draft G.S.R.152(E)_Condition of licence for undertaking on brand or trade names of drugs |
2019-Feb-26 |
|
325 KB |
| 218 |
2019.02.08_S.O. 775(E)_ Notification of certain medical devices (8 no's) under definition of drug_Section 3(b)(iv) |
2019-Feb-08 |
|
265 KB |
| 219 |
2019.02.05_S.O. 697(E)_Revoke of FDC banned notification S.O. 4616(E) dated 07.09.2018_Section 26A |
2019-Feb-05 |
|
282 KB |
| 220 |
2019.02.04_Draft GSR 88(E)_Omission of provision for writing brand name in brackets in Rule 96 of D &C Rules, 1945 |
2019-Feb-04 |
|
312 KB |
| 221 |
2019.02.04_Draft GSR 87(E)_Exqmption of State Central Govt testing labs from NABL accreditation for two years under MDR, 2017 |
2019-Feb-04 |
|
329 KB |
| 222 |
25.01.2019_Final GSR 47(E)_Exemption of 100mL single use sterile parenteral solutions for export under Schedule K |
2019-Jan-25 |
|
346 KB |
| 223 |
2019.01.15_ Fina GSR 30(E)_Rule 3 Rule 59, 4th and 7th Schedules of MDR 2017 for insertion of e-IFU |
2019-Jan-15 |
|
314 KB |
| 224 |
2019.01.11_S.O. 180(E) to S.O.259(E)_Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
2019-Jan-11 |
|
1964 KB |
| 225 |
2019.01.10_Final GSR 20(E)__Notification of Mundra port and Kamarajar port under Rule 43A |
2019-Jan-10 |
|
292 KB |
| 226 |
2019.01.10_Final GSR 19(E)_Provision for information to be uploaded by licensee on SUGAM portal |
2019-Jan-10 |
|
238 KB |
| 227 |
018.12.13 S.O.6161(E) Restriction of Buclizine and its formulations as appetite stimulant under Section 26A |
2018-Dec-13 |
|
286 KB |
| 228 |
12018.12.12_Final_GSR 1193(E)_Fee Revision for registration and import license under D and C Rules, 1945 |
2018-Dec-12 |
|
312 KB |
| 229 |
2018.12.10_Draft_GSR 1190(E)_Date of implementation of G.S.R. 277(E) dated 23.03.2018 |
2018-Dec-10 |
|
290 KB |
| 230 |
2018.12.07_Draft_GSR 1185(E)_Date of implementation of GSR 408(E) dated 26.04.2018 |
2018-Dec-07 |
|
306 KB |
| 231 |
2018.12.07_ Final_GSR1186(E)_ Approved or permitted color in gelatine capsule Rule127(2) |
2018-Dec-07 |
|
306 KB |
| 232 |
2018.12.07_Draft_GSR 1187(E)_Amendment of Rule 91 and the Second Schedule for fees of free sale certificate in the MDR, 2017 |
2018-Dec-07 |
|
340 KB |
| 233 |
S.O. 5980(E) dated 03.12.2018 |
2018-Dec-03 |
|
279 KB |
| 234 |
2018.12.03_ S.O.5980_ Inclusion of four Medical devices in definition of drugs |
2018-Dec-03 |
|
279 KB |
| 235 |
2018.12.03_ Final_GSR 1161(E)_Amendment in Rule 96 and Date of implemention of GSR 222(E) dated 13.03.2018 |
2018-Dec-03 |
|
308 KB |
| 236 |
S.O.5980(E)-03-12-2018 |
2018-Dec-03 |
|
279 KB |
| 237 |
2018.11.29_Draft G.S.R. 1153(E)_Reg. Cosmetics Rules, 2018 |
2018-Nov-29 |
|
1276 KB |
| 238 |
2018.11.29_ Draft G.S.R. 1152(E)_Amendment in Part X B Part XII B pertains to Blood centre and Blood components |
2018-Nov-29 |
|
692 KB |
| 239 |
S.O. 1352(E) dated 23.03.2018_G.S.R. 1074(E) dated 30.10.2018 |
2018-Oct-30 |
|
445 KB |
| 240 |
2018 october 30 GSR 1074E Prohibition of import of Rapid Diagnostic Tests for MalariaSection 10A |
2018-Oct-30 |
|
399KB |
| 241 |
Notification of Mundra and Kamarajar Ports under Rule 43A, Draft GSR 1051(E) |
2018-Oct-25 |
|
304KB |
| 242 |
2018-10-05_Draft GSR 999(E)_Upgradation of Sch M GMP |
2018-Oct-05 |
|
4311 KB |
| 243 |
2018-10-05_Draft GSR 1000(E)_Fee Revision For Various Licensing Activities |
2018-Oct-05 |
|
1577 KB |
| 244 |
2018.09.25_S.O. 4972,4973 4974_Corrigendums to S.O. dated 07.09.2018 |
2018-Sep-25 |
|
1551 KB |
| 245 |
2018-09-25_Draft GSR 922(E)_Hydroquinone included in Note to Sch H |
2018-Sep-25 |
|
1660 KB |
| 246 |
2018-09-07_Draft GSR 848(E)_Rule 3, Rule 59, Fourth ScheduleSeventh Schedule of MDR 2017 |
2018-Sep-07 |
|
1712 KB |
| 247 |
2018.09.07_S.O. 4379(E) to S.O.4712 (E)_Prohibition and Restriction of FDC drugs_Section 26A |
2018-Sep-07 |
|
7414 KB |
| 248 |
2018.08.28_Draft GSR 817(E)_Sale of Drugs by E-Pharmacy |
2018-Aug-28 |
|
1896 KB |
| 249 |
2018-08-27_Draft GSR 813(E)_Amendment of Form 45 & 46 for Package Insert |
2018-Aug-27 |
|
1720 KB |
| 250 |
2018.08.21_Final GSR 794(E) and 795(E)_Mfg of Oxytocin Formulation Scheduling of Oxytocin in Sch H1 omittion from Sch H |
2018-Aug-21 |
|
1,709 KB |
| 251 |
2018.08.10_Draft GSR 763(E)_Inclusion of Oxytocin under Schedule H1 |
2018-Aug-10 |
|
1,785,856 KB |
| 252 |
G.S.R. 729 (E) dated 01.08.2018 |
2018-Aug-01 |
|
1742 KB |
| 253 |
2018.08.01_Final _GSR 729 (E) _Amendment of Performance evaluation report of in-vitro diagnostic medical devices |
2018-Aug-01 |
|
1,785,856 KB |
| 254 |
2018.07.30_Draft_GSR 719(E)_ Exemption of parenteral sterile solutions with 100 mL capacity for export by 100EOUs under Schedule K |
2018-Jul-30 |
|
1,755KB |
| 255 |
2018.07.30_Draft_GSR 721(E)_Amendment in Rule 127 reg. indication of colour in case of gelatine capsules |
2018-Jul-30 |
|
1,762 KB |
| 256 |
2018.07.30_Draft_GSR 720(E)_Inclusion of Form 39A_Report of test or analysis by approved institution |
2018-Jul-30 |
|
1,809 KB |
| 257 |
2018.07.19_Draft_GSR 660(E)_Amendment in Environmental requirements for mfg. of Medical Devices_Annexure- A of the Fifth Schedule of MDR, 2017 |
2018-Jul-19 |
|
1,806,336 KB |
| 258 |
2018.07.17_Draft_GSR 654(E)_Notifcation of Chaudhary Charan Singh National Institute of Animal Health, UP for testing of Veterinary Vaccines |
2018-Jul-17 |
|
1,794,048 KB |
| 259 |
2018.07.11_S.O.3400 (E)_ Notification of Medical Device Testing Officers (MDTO) |
2018-Jul-11 |
|
2,150,400 KB |
| 260 |
S.O. 3400(E) dated 11.07.2018 |
2018-Jul-11 |
|
2089 KB |
| 261 |
2018.07.11_Draft GSR 629 (E)Information to be uploaded on SUGAM by license |
2018-Jul-11 |
|
1,822,720 KB |
| 262 |
2018.07.03_Draft GSR 608E)_Perpetual Licensing |
2018-Jul-03 |
|
1,830,375 KB |
| 263 |
2018.06.29_GSR 602(E)_Extention of implementation date for GSR 411(E) dated 27.04.2018 |
2018-Jun-29 |
|
1,790,846 KB |
| 264 |
S.O. 2237(E) dated 01.06.2018 |
2018-Jun-01 |
|
1752 KB |
| 265 |
S.O. 2237(E) |
2018-Jun-01 |
|
1,752KB |
| 266 |
2018.05.15 Final S.O. 1929(E)_Reconstitution of DTAB 2018 |
2018-May-15 |
|
1,778KB |
| 267 |
Draft GSR 412 (E) Dt.27.04.2018_Reg. performance evaluation report of IVD medical devices |
2018-Apr-27 |
|
1,747KB |
| 268 |
GSR 411(E) dt 27.04.2018_Manufacture Prohibition of Oxytocin with conditions under Section 26A |
2018-Apr-27 |
|
1,745KB |
| 269 |
GSR 408 (E) dated 26.04.2018 Final amendment of Rule 96 Rule 97 Sch H Sch K |
2018-Apr-26 |
|
1,769KB |
| 270 |
GSR 390(E) dated 24.04.2018_Import banning of Oxytocin under Section 10A |
2018-Apr-24 |
|
1,721KB |
| 271 |
April 19th 2018 GSR 385(E) |
2018-Apr-19 |
|
1,780KB |
| 272 |
April 18th 2018 GSR 381(E) |
2018-Apr-18 |
|
1,763KB |
| 273 |
April 12th 2018 GSR 366(E) |
2018-Apr-12 |
|
1,740KB |
| 274 |
April 10th 2018 GSR 360(E) |
2018-Apr-10 |
|
1,730KB |
| 275 |
March 23rd 2018 GSR 1352(E) |
2018-Mar-23 |
|
1,688KB |
| 276 |
March 23rd 2018 GSR 277(E) |
2018-Mar-23 |
|
1,707KB |
| 277 |
F.No. Z-28015-2-2012-TB Dt.16.03.2018 Reg. Tuberculosis diagnosis and its management in patients |
2018-Mar-19 |
|
2,075KB |
| 278 |
March 13th 2018 GSR 222(E) |
2018-Mar-13 |
|
1,698KB |
| 279 |
2018.03.07_Final GSR 76_ Notification of Medical Device Officers (MDO) |
2018-Mar-07 |
|
1846 KB |
| 280 |
List of PUSR meeting17 |
2018-Feb-09 |
|
7kb |
| 281 |
CTD Guidance Final |
2018-Feb-09 |
|
816kb |
| 282 |
Extension of Expert Committee |
2018-Feb-09 |
|
667kb |
| 283 |
List of Bulk Drug Registered from 2007-july 2009 |
2018-Feb-09 |
|
202kb |
| 284 |
February 1st 2018 GSR 104(E) |
2018-Feb-01 |
|
3,859KB |
| 285 |
November 14th 2017 S.O 3609(E) |
2017-Nov-16 |
|
1,649KB |
| 286 |
G.S.R 3609(E) |
2017-Nov-14 |
|
1,649KB |
| 287 |
November 10th 2017 GSR 1380(E) |
2017-Nov-10 |
|
1,645KB |
| 288 |
November 3rd 2017 GSR 1367(E) |
2017-Nov-03 |
|
1,595KB |
| 289 |
November 3rd 2017 GSR 1368(E) |
2017-Nov-03 |
|
1,585KB |
| 290 |
November 3rd 2017 GSR 1369(E) |
2017-Nov-03 |
|
1,667KB |
| 291 |
November 1st 2017 GSR 1357(E) |
2017-Nov-01 |
|
1,534KB |
| 292 |
October 27th 2017 GSR 1337(E) |
2017-Oct-27 |
|
1,625KB |
| 293 |
June 8th 2017 S.O 1851(E),1852 (E), 1853 (E),1854 (E), 1855(E) |
2017-Jun-08 |
|
1,217KB |
| 294 |
May 2nd 2017 GSR 429(E) |
2017-May-02 |
|
510KB |
| 295 |
April 13th 2017 GSR 367(E) |
2017-Apr-13 |
|
1,157KB |
| 296 |
April 3rd 2017 GSR 329(E) |
2017-Apr-03 |
|
1,202KB |
| 297 |
April 3rd 2017 GSR 327(E) |
2017-Apr-03 |
|
1,205KB |
| 298 |
April 3rd 2017 GSR 328(E) |
2017-Apr-03 |
|
299KB |
| 299 |
March 31 2017 GSR 319(E) |
2017-Mar-31 |
|
1,201KB |
| 300 |
March 30 2017 GSR 302(E) |
2017-Mar-30 |
|
1,149KB |
| 301 |
March 30 2017 GSR 303(E) |
2017-Mar-30 |
|
1,149KB |
| 302 |
March 15 2017 GSR 250(E) |
2017-Mar-15 |
|
1,156KB |
| 303 |
6th October 2005 (SO 1468(E) |
2017-Feb-17 |
|
69 KB |
| 304 |
S.O. 2237(E)_Notification on Central Medical Device Testing Laboratory under MDR 2017 |
2017-Feb-17 |
|
1752 KB |
| 305 |
7th October 2005 (GSR 627 (E) |
2017-Feb-17 |
|
66 KB |
| 306 |
GSR 600 (E) Drugs [IVD's] |
2017-Feb-17 |
|
1336 KB |
| 307 |
24th October 2013 (GSR 703 (E) |
2017-Feb-17 |
|
558 KB |
| 308 |
February 17 2017 GSR 144(E) |
2017-Feb-17 |
|
1,132KB |
| 309 |
February 17 2017 GSR 145(E) |
2017-Feb-17 |
|
1,131KB |
| 310 |
TB Sero Notification [IVD's |
2017-Feb-17 |
|
136 KB |
| 311 |
27th August 2002 GSR 601 (E) |
2017-Feb-17 |
|
217 KB |
| 312 |
17th March 1989 GSR 365 (E) |
2017-Feb-17 |
|
166 KB |
| 313 |
May 19,2010(G.S.R_426 E) |
2017-Feb-17 |
|
681 KB |
| 314 |
G.S.R. 103(E) dated 02.02.2017 |
2017-Feb-02 |
|
1121 KB |
| 315 |
February 2nd 2017 GSR 102(E) |
2017-Feb-02 |
|
1,120KB |
| 316 |
February 2nd 2017 GSR 103(E) |
2017-Feb-02 |
|
1,121KB |
| 317 |
February 2nd 2017 GSR 101(E) |
2017-Feb-02 |
|
1,116KB |
| 318 |
February 1st 2017 GSR 80(E) |
2017-Feb-01 |
|
1,139KB |
| 319 |
Medical Device Rule 2017 - GSR 78(E) Dated- 31.01.2017 |
2017-Jan-31 |
|
3029 KB |
| 320 |
January 31 2017 GSR 78(E) |
2017-Jan-31 |
|
3,029KB |
| 321 |
January 31 2017 GSR 76(E) |
2017-Jan-31 |
|
1,125KB |
| 322 |
G.S.R. 78(E) dated 31.01.2017 |
2017-Jan-31 |
|
3029 KB |
| 323 |
Mercury Limit-GSR56(E) |
2017-Jan-19 |
|
1,107kb |
| 324 |
January 19 2017 GSR 56(E) |
2017-Jan-19 |
|
1,107KB |
| 325 |
January 17 2017 GSR 44(E) |
2017-Jan-17 |
|
1,105KB |
| 326 |
January 17 2017 GSR 41(E) |
2017-Jan-17 |
|
1,136KB |
| 327 |
January 17 2017 GSR 42(E) |
2017-Jan-17 |
|
1,103KB |
| 328 |
January 17 2017 GSR 43(E) |
2017-Jan-17 |
|
1,106KB |
| 329 |
January 16 2017 GSR 36(E) |
2017-Jan-16 |
|
1,102KB |
| 330 |
December 28 2016 GSR 1179(E) |
2016-Dec-28 |
|
227KB |
| 331 |
November 8 2016 GSR 1050(E) |
2016-Nov-08 |
|
968KB |
| 332 |
November 4 2016 GSR 1041(E) |
2016-Nov-04 |
|
962KB |
| 333 |
October 17 2016 GSR 983(E) |
2016-Oct-17 |
|
3,016KB |
| 334 |
September 21 2016 GSR 897(E) |
2016-Sep-21 |
|
240KB |
| 335 |
August 23 2016 GSR 812(E) |
2016-Aug-23 |
|
241KB |
| 336 |
August 12 2016 GSR790(E) |
2016-Aug-12 |
|
878KB |
| 337 |
August 4 2016 SO2612(E) |
2016-Aug-04 |
|
62KB |
| 338 |
June 29 2016 GSR 640(E) |
2016-Jun-29 |
|
484KB |
| 339 |
GSR 640 (E) dated 29.06.2016 regarding Schedule - MIII - Requirement of QMS for Medical Devices |
2016-Jun-17 |
|
484 KB |
| 340 |
2016.05.04_S.O. 1326(E)_Notification for Government Analyst_Dr. Raman Mohan Singh, Dir, CDTL, Mumbai |
2016-May-04 |
|
33 KB |
| 341 |
March 29 2016 GSR 357(E) |
2016-Mar-29 |
|
470KB |
| 342 |
March 16 2016 GSR 313(E) |
2016-Mar-16 |
|
131KB |
| 343 |
March 16 2016 GSR 312(E) |
2016-Mar-16 |
|
135KB |
| 344 |
March 10 2016 S.O 705(E) TO 1048(E) |
2016-Mar-10 |
|
2,744KB |
| 345 |
March 08 2016 GSR 287(E) |
2016-Mar-08 |
|
151KB |
| 346 |
March 01 2016 GSR 268(E) |
2016-Mar-01 |
|
127KB |
| 347 |
January 25,2016 S.O 237(E) |
2016-Jan-25 |
|
263KB |
| 348 |
January 06,2016 GSR 11(E) |
2016-Jan-06 |
|
150KB |
| 349 |
December 29, 2015 GSR 1011(E) |
2015-Dec-29 |
|
197KB |
| 350 |
November 30 2015 GSR 918(E) |
2015-Nov-30 |
|
124KB |
| 351 |
October 30 2015 GSR 826(E) |
2015-Oct-30 |
|
179KB |
| 352 |
August 20 2015 GSR 648(E) |
2015-Aug-20 |
|
276KB |
| 353 |
July 31 2015 GSR 611(E) |
2015-Jul-31 |
|
1,329KB |
| 354 |
July 17 2015 GSR 558(E) |
2015-Jul-17 |
|
155KB |
| 355 |
July 17 2015 GSR 559(E) |
2015-Jul-15 |
|
290KB |
| 356 |
June 16 2015 S.O 1597(E) |
2015-Jun-16 |
|
96KB |
| 357 |
June 3 2015 GSR 449(E) |
2015-Jun-03 |
|
1,337KB |
| 358 |
April 15 2015 GSR 289(E) |
2015-Apr-15 |
|
207KB |
| 359 |
March 30 2015 SO 873(E) |
2015-Mar-30 |
|
500KB |
| 360 |
Notification for different banks-GSR 873(E) |
2015-Mar-30 |
|
500kb |
| 361 |
March 25 2015 GSR 224(E) |
2015-Mar-25 |
|
639KB |
| 362 |
March 18 2015 GSR 203(E) |
2015-Mar-18 |
|
170KB |
| 363 |
Feb 17 2015 GSR 107(E) |
2015-Feb-17 |
|
131KB |
| 364 |
Feb 5 2015 GSR SO 375(E) |
2015-Feb-05 |
|
129KB |
| 365 |
Feb 5 2015 GSR 74(E) |
2015-Feb-05 |
|
154KB |
| 366 |
Feb 5 2015 GSR SO 376(E) |
2015-Feb-05 |
|
136KB |
| 367 |
Feb 3 2015 GSR 69(E) |
2015-Feb-03 |
|
232KB |
| 368 |
Feb 3 2015 GSR 68(E) |
2015-Feb-03 |
|
224KB |
| 369 |
Jan 16 2015 GSR 38(E) |
2015-Jan-16 |
|
882KB |
| 370 |
Dec 29 2014 SO 3298(E) |
2014-Dec-29 |
|
144KB |
| 371 |
Dec 22 2014 GSR 908(E) |
2014-Dec-22 |
|
138KB |
| 372 |
G.S.R. 908 (E) dated 22.12.2014 |
2014-Dec-22 |
|
138 KB |
| 373 |
Dec 12 2014 GSR 889(E) |
2014-Dec-12 |
|
452KB |
| 374 |
S.O.2617(E)_2014.10.13 Notification of Drugs Inspector |
2014-Oct-13 |
|
179 KB |
| 375 |
Sep 29 2014 GSR 701(E) |
2014-Sep-29 |
|
175KB |
| 376 |
G.S.R 690(E) |
2014-Sep-25 |
|
222kb |
| 377 |
Sep 25 2014 GSR 690(E) |
2014-Sep-25 |
|
222KB |
| 378 |
Sep 02 2014 GSR 633(E) |
2014-Sep-02 |
|
111KB |
| 379 |
Aug 07 2014 GSR 570(E) |
2014-Aug-07 |
|
180KB |
| 380 |
July 14 2014 GSR 503(E) |
2014-Jul-14 |
|
84KB |
| 381 |
July 14 2014 GSR 502(E) |
2014-Jul-14 |
|
78KB |
| 382 |
July 11.2014 GSR 498(E) |
2014-Jul-11 |
|
82KB |
| 383 |
May 23 2014 G.S.R 350(E) |
2014-May-23 |
|
98KB |
| 384 |
Animal Testing Ban-GSR 346(E) |
2014-May-21 |
|
922kb |
| 385 |
May 21 2014 G.S.R 346(E) |
2014-May-21 |
|
922KB |
| 386 |
May 5.2014 G.S.R. 310(E) |
2014-May-05 |
|
792KB |
| 387 |
May 5.2014 G.S.R.312(E) |
2014-May-05 |
|
1,097KB |
| 388 |
May 5 2014 G.S.R 311(E) |
2014-May-05 |
|
871KB |
| 389 |
April 24.04.2014 G.S.R 292 (E) |
2014-Apr-24 |
|
116KB |
| 390 |
Import Animal Testing Ban-G.S.R.718(E) |
2014-Mar-13 |
|
168kb |
| 391 |
March 11.03.2014 G.S.R 176 (E) |
2014-Mar-11 |
|
96KB |
| 392 |
February 13.02.2014 G.S.R 86 (E) |
2014-Feb-13 |
|
510KB |
| 393 |
Jan 17.01.2014 G.S.R. 29 (E) |
2014-Jan-17 |
|
432KB |
| 394 |
Dec 23.12.2013 GSR 3793(E) |
2013-Dec-23 |
|
135KB |
| 395 |
S.G 3793(E) |
2013-Dec-23 |
|
135kb |
| 396 |
Nov 07.11.2013 GSR 724(E) |
2013-Nov-07 |
|
717KB |
| 397 |
2013.11.07_S.O. 3395(E)_Notification for Appointment of Drugs Inspectors |
2013-Nov-07 |
|
213 KB |
| 398 |
Nov24.11.2013 GSR 702 (E) |
2013-Oct-24 |
|
3,688KB |
| 399 |
October 24.10.2013 GSR 703(E) |
2013-Oct-24 |
|
693KB |
| 400 |
August 30.08.2013 GSR 589 (E) |
2013-Aug-30 |
|
73KB |
| 401 |
August 30.08.2013 GSR 588 (E) |
2013-Aug-30 |
|
180KB |
| 402 |
August 30.08.2013 GSR 590(E) |
2013-Aug-30 |
|
55KB |
| 403 |
July 31.07.2013 GSR 520(E) |
2013-Jul-31 |
|
1,948KB |
| 404 |
June 18.06.2013 G.S.R 378(E) |
2013-Jun-18 |
|
363KB |
| 405 |
June 18.06.2013 G.S.R 379(E) |
2013-Jun-18 |
|
250KB |
| 406 |
June 18.06.2013 G.S.R 377(E) |
2013-Jun-18 |
|
428KB |
| 407 |
June 07.06.2013 G.S.R 364 (E) |
2013-Jun-07 |
|
494KB |
| 408 |
May 23.05.2013 (GSR 332(E) |
2013-May-23 |
|
265KB |
| 409 |
Feb 08.02.2013 (GSR 72(E) |
2013-Feb-08 |
|
4,257KB |
| 410 |
Feb 01.02.2013 (GSR 63 E) |
2013-Feb-01 |
|
1,256KB |
| 411 |
January 30.01.2013 (GSR 53 E) |
2013-Jan-30 |
|
596KB |
| 412 |
January 24.01.2013 (GSR 43E) |
2013-Jan-24 |
|
2,745KB |
| 413 |
2012.11.30_S.O. 2810(E)_Notification of GA of CDL Kolkata |
2012-Nov-30 |
|
32 KB |
| 414 |
2012.11.30_ S.O. 2808 (E) GA notification at CDTL Mumbai |
2012-Nov-30 |
|
41 KB |
| 415 |
November 08,2012 ( G.S.R 816 (E) ) |
2012-Nov-08 |
|
1,003KB |
| 416 |
2012.10.19_S.O. 2527(E)_Notification of Subrat Kumar CDL kolkata |
2012-Oct-19 |
|
38 KB |
| 417 |
Octboer 05.10.2012(G.S.R 748(E)) |
2012-Oct-05 |
|
284KB |
| 418 |
September 29,2012 (G.S.R. 733(E)) |
2012-Sep-29 |
|
284KB |
| 419 |
July 17, 2012 (GSR 574(E)) |
2012-Jul-17 |
|
1,787KB |
| 420 |
July 17, 2012 (GSR 572(E) |
2012-Jul-17 |
|
1,446KB |
| 421 |
July 17, 2012 (GSR 573(E)) |
2012-Jul-17 |
|
2,939KB |
| 422 |
July 17, 2012 (GSR 575(E)) |
2012-Jul-17 |
|
828KB |
| 423 |
GSR 433 (E) dated 7.June 2012 |
2012-Jun-07 |
|
136 KB |
| 424 |
March 30, 2012 (GSR 270(E) |
2012-Mar-30 |
|
254KB |
| 425 |
2012.03.29_S.O. 652(E)_Dr. M.F.A. Beg, SSO, CDL, Kolkata_Signing Authority_COA |
2012-Mar-29 |
|
44 KB |
| 426 |
March 20, 2012 (GSR 228(E)) |
2012-Mar-20 |
|
1,293KB |
| 427 |
January 17,2012 (GSR 28(E) |
2012-Jan-17 |
|
51KB |
| 428 |
December 27, 2011 (GSR 899(E) |
2011-Dec-27 |
|
7,384KB |
| 429 |
Nov 18, 2011 (GSR 821(E)) |
2011-Nov-18 |
|
1,160KB |
| 430 |
November 3, 2011 ( S.O. 2496(E) |
2011-Nov-03 |
|
175KB |
| 431 |
October 12, 2011 (GSR 752 (E)) |
2011-Oct-12 |
|
78KB |
| 432 |
Sept 29, 2011 (GSR 733(E)) |
2011-Sep-29 |
|
70KB |
| 433 |
July 21, 2011, (GSR 557 (E) |
2011-Jul-21 |
|
688KB |
| 434 |
June 2, 2011, (GSR 425 (E) |
2011-Jun-02 |
|
127KB |
| 435 |
May 30, 2011 (GSR 418 (E) |
2011-May-30 |
|
149KB |
| 436 |
April 8, 2011 (S.O 722 (E) |
2011-Apr-08 |
|
196KB |
| 437 |
Notification - Extension of Import registration - Gazette notification G.S.R. 263(E), Mar 30, 2011 |
2011-Mar-30 |
|
66KB |
| 438 |
Notification, Mar 16, 2011 (G.S.R. 218 (E) |
2011-Mar-16 |
|
75KB |
| 439 |
Notification, Feb 18, 2011 (G.S.R.101(E)) |
2011-Feb-18 |
|
1,802KB |
| 440 |
Drugs Prohibited vide Gazette notification, Feb 10, 2011 (G.S.R.82(E)) |
2011-Feb-10 |
|
84KB |
| 441 |
Jan 24, 2011 (G.S.R 45 (E)) |
2011-Jan-24 |
|
123KB |
| 442 |
Jan 19, 2011 (G.S.R 40 (E)) |
2011-Jan-19 |
|
566KB |
| 443 |
Nov 12, 2010 (G.S.R 910E) |
2010-Nov-12 |
|
79KB |
| 444 |
Registration for Import of cosmetics-GSR 426(E) |
2010-May-19 |
|
9,488kb |
| 445 |
April 9,2010(G.S.R_303 E) |
2010-Apr-09 |
|
1,717KB |
| 446 |
Jan21,2010(G.S.R_45(E) |
2010-Jan-21 |
|
996KB |
| 447 |
Dec22,2009(G.S.R_917(E) |
2009-Dec-22 |
|
1,369KB |
| 448 |
Dec_11,2009(G.S.R_884(E) |
2009-Dec-11 |
|
824KB |
| 449 |
Dec_11,2009(G.S.R_885(E) |
2009-Dec-11 |
|
1,395KB |
| 450 |
Nov_14,2009(S.O.3077) |
2009-Nov-14 |
|
461KB |
| 451 |
Oct_29,2009(G.S.R_790(E) |
2009-Oct-29 |
|
1,248KB |
| 452 |
Sept 15,2009(G.S.R 677 E) |
2009-Sep-15 |
|
1,314KB |
| 453 |
Sept_9,2009(G.S.R_651(E) |
2009-Sep-09 |
|
1,380KB |
| 454 |
Aug_28,2009(G.S.R_607(E) |
2009-Aug-28 |
|
827KB |
| 455 |
June 16,2009 (G.S.R.355) |
2009-Jun-16 |
|
451KB |
| 456 |
June 16, 2009 (G.S.R.354) |
2009-Jun-16 |
|
7,668KB |
| 457 |
G.S.R 45(E) dated 22.01.2009 Drugs and Cosmetics First Amendment Rules 2009 |
2009-Jan-22 |
|
68 KB |
| 458 |
G.S.R 46(E) dated 22.01.2009 Drugs and Cosmetics First Amendment Rules 2009 |
2009-Jan-22 |
|
87 KB |
| 459 |
July 5,2008 (G.S.R 364) |
2008-Jul-05 |
|
478KB |
| 460 |
April 16,2008 (G.S.R.207) |
2008-Apr-16 |
|
1,271KB |
| 461 |
2nd February 2007(G.S.R 62(E)) |
2007-Feb-02 |
|
316KB |
| 462 |
2nd February 2007 (G.S.R. 63(E)) |
2007-Feb-02 |
|
362KB |
| 463 |
16th March 2006(GSR 160 (E)) |
2006-Mar-16 |
|
742KB |
| 464 |
7th Oct 2005(GSR 627 (E)) |
2005-Oct-07 |
|
66KB |
| 465 |
G.S.R 627(E) |
2005-Oct-07 |
|
66kb |
| 466 |
S.O 1468(E) |
2005-Oct-06 |
|
69kb |
| 467 |
6th Oct 2005(SO 1468 (E) regarding sterile devices intended for exteranl or internal use in human beings as drugs |
2005-Oct-06 |
|
69 KB |
| 468 |
28th July 2005(GSR 510 (E)) |
2005-Jul-28 |
|
57KB |
| 469 |
30th June 2005(GSR 431 (E)) |
2005-Jun-30 |
|
473KB |
| 470 |
GSR_601_E_27-08-2002 |
2002-Aug-27 |
|
1336 KB |
| 471 |
G.S.R. 600(E) |
2002-Aug-07 |
|
1336kb |
| 472 |
1st May 2002 (GSR 311(E)) |
2002-May-01 |
|
129KB |
| 473 |
G.S.R. 365(E) |
1989-Jun-17 |
|
166kb |
